Evaluation, Treatment, and Training for Patients With Blood Disorders
Completed
Conditions studied: Hematologic Diseases
In brief
This study is designed to allow the evaluation, follow-up, and medical care of patients with blood disorders not currently participating in a research study being conducted by the Hematology Branch of the National Heart, Lung and Blood Institute (NHLBI) or not being screened for participation in a study. The purpose of this study is to allow investigation into the blood disorders of patients in order to teach, learn, and gather more information about diseases of the blood. In addition, this study allows researchers the opportunity to evaluate patients referred to the Hematology Branch of the NHLBI with rare or undiagnosed diseases of the blood. This may be potentially beneficial to the patient and at the same time contribute to the development of new research ideas.
Key facts
- Study ID
- NCT00001397
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
- People needed
- 1452
- Starts
- 1993-11-08
- Expected to finish
- 2020-10-05
- Last updated by the study team
- 2020-10-08
Who can join
Age: 2 and older, up to 110. Sex: any. Healthy volunteers: not accepted.
Where it is running
- National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.